Your browser doesn't support javascript.
loading
A landscape of liver cirrhosis and transplantation in Mexico: Changing leading causes and transplant as response.
Palma-Lara, Icela; Ortiz-López, María Guadalupe; Bonilla-Delgado, José; Pérez-Escobar, Juanita; Godínez-Aguilar, Ricardo; Luévano-Contreras, Claudia; Espinosa-García, Ana María; Pérez-Durán, Javier; García Alonso-Themann, Patricia; Nolasco-Quiroga, Manuel; Flores-Estrada, Javier; Carpinteyro-Espin, Paulina; Juárez-Ascencio, Daniel; Nieto-Velazquez, Nayeli Goreti; Palacios-Reyes, Carmen.
Afiliación
  • Palma-Lara I; Laboratorio de Morfología Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico. Electronic address: icelitpl@yahoo.com.
  • Ortiz-López MG; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: gortizl@prodigy.net.mx.
  • Bonilla-Delgado J; Unidad de Investigación, Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca 56530, Mexico; Departamento de Biotecnología, Escuela de Ingeniería y Ciencias, Instituto Tecnológico de Monterrey, Toluca de Lerdo 50110, Mexico. Electronic address: jbonilla@cinvestav.mx.
  • Pérez-Escobar J; Servicio de Trasplantes, División de Cirugía, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: drajsperez@gmail.com.
  • Godínez-Aguilar R; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: raa_rga@yahoo.com.mx.
  • Luévano-Contreras C; Departamento de Ciencias Médicas, División de Ciencias de la Salud, Universidad de Guanajuato, Campus León, Guanajuato 37000, México. Electronic address: c.luevanocontreras@ugto.mx.
  • Espinosa-García AM; Laboratorio de Farmacología Clínica, Hospital General de México, Mexico City 06720, México. Electronic address: anaesga@hotmail.com.
  • Pérez-Durán J; Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, México. Electronic address: djavier40@gmail.com.
  • García Alonso-Themann P; Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, México. Electronic address: pgalonsot@yahoo.com.
  • Nolasco-Quiroga M; Coordinación de Enseñanza e Investigación, Clínica Hospital Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Huauchinango 73177, Mexico. Electronic address: m_nolasco_quiroga@hotmail.com.
  • Flores-Estrada J; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: javier_70_1999@yahoo.com.
  • Carpinteyro-Espin P; Servicio de Trasplantes, División de Cirugía, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: paucarpi@gmail.com.
  • Juárez-Ascencio D; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: juarez_a@yahoo.com.mx.
  • Nieto-Velazquez NG; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico. Electronic address: goretinieto@gmail.com.
  • Palacios-Reyes C; Laboratorio de Morfología Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico; Departamento de Ciencias Médicas, División de
Ann Hepatol ; 30(1): 101562, 2024 Sep 13.
Article en En | MEDLINE | ID: mdl-39278408
ABSTRACT
Liver cirrhosis causes include alcoholism, viral infections (hepatitis B virus (HBV) and hepatitis C virus (HCV)), alcohol-associated liver disease (ALD), and metabolic dysfunction associated with steatotic liver disease (MASLD), among others. Cirrhosis frequency has increased in recent years, with a prevalence of 1395 cases per 100,000 and a mortality rate of 18 per 100,000, which corresponded to 1,472,000 deaths during 2017. In Mexico, liver disease is a public health problem since it was associated to 41,890 deaths in 2022, including liver cirrhosis (>25,000) and ALD (14,927). This represents 114 daily deaths due to these causes, and corresponds to the 4th or 5th place of all causes. The global prevalence of MASLD is estimated to affect 25% of the world's population, while in the pediatric population it could be higher. In Mexican population it is more prevalent since estimations were around 41.3% in 2023. Alcohol consumption, a global health issue due to its high prevalence and associated morbidities, is associated to ALD in 32.9%, with a mortality rate of 23.9%, primarily due to liver-related causes. In Mexico, ALD is present in 23% of all cirrhosis cases, already surpassed by hepatitis B cases in 2009. HCV and HBV frequencies changed due to programs implementing screening detection, vaccines and direct-acting antivirals during the last years. A switch of causes has occurred, increasing MASLD and diminishing viral causes. Efficient performed liver transplantation has grown as a response to increasing cirrhosis cases, including recent authorized centers. These efforts are necessary, whereas preventive strategies should be implemented according to leading causes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: Mexico Idioma: En Revista: Ann Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: México

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: Mexico Idioma: En Revista: Ann Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: México